Study of CAR T-Cell therapy trial in India, in leukaemia patients, shows 73% response rate
Study of CAR T-Cell therapy trial in India, in leukaemia patients, shows 73% response rate
You may also like
Health
Sleepless nights? Here’s a drug to help Premium
Sleepless nights? Here’s a drug to help Premium (In the weekly Health Matters newsletter, Ramya Kannan writes about getting to
Health
Journal finally retracts the discredited hydroxychloroquine paper Premium
Journal finally retracts the discredited hydroxychloroquine paper Premium More than four-and-a-half years after the highly questionable “study” by a French researcher Didier